Close

Cytokeratin 19

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

The type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. Unlike its related family members, this smallest known acidic cytokeratin is not paired with a basic cytokeratin in epithelial cells. It is specifically expressed in the periderm, the transiently superficial layer that envelopes the developing epidermis. The type I cytokeratins are clustered in a region of chromosome 17q12-q21.
  • CAR Vector Products

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAART-LX291 Anti-Cytokeratin 19 (BA-17) h(CD28-CD3ζ) CAART, pCDCAAR1 Human BA-17 Mouse scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX292 Anti-Cytokeratin 19 (E6) h(CD28-CD3ζ) CAART, pCDCAAR1 Human E6 Mouse scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX293 Anti-Cytokeratin 19 (EP1580Y) h(CD28-CD3ζ) CAART, pCDCAAR1 Human EP1580Y Rabbit scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX294 Anti-Cytokeratin 19 (A53-B/A2) h(CD28-CD3ζ) CAART, pCDCAAR1 Human A53-B/A2 Mouse scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX295 Anti-Cytokeratin 19 (A-3) h(CD28-CD3ζ) CAART, pCDCAAR1 Human A-3 Mouse scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX296 Anti-Cytokeratin 19 (3F8) h(CD28-CD3ζ) CAART, pCDCAAR1 Human 3F8 Mouse scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX297 Anti-Cytokeratin 19 (ABT-CK19) h(CD28-CD3ζ) CAART, pCDCAAR1 Human ABT-CK19 Mouse scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX298 Anti-Cytokeratin 19 (LE64) h(CD28-CD3ζ) CAART, pCDCAAR1 Human LE64 Mouse scFv-CD28-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX299 Anti-Cytokeratin 19 (BA-17) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human BA-17 Mouse scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX300 Anti-Cytokeratin 19 (E6) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human E6 Mouse scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX301 Anti-Cytokeratin 19 (EP1580Y) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human EP1580Y Rabbit scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX302 Anti-Cytokeratin 19 (A53-B/A2) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human A53-B/A2 Mouse scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX303 Anti-Cytokeratin 19 (A-3) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human A-3 Mouse scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX304 Anti-Cytokeratin 19 (3F8) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human 3F8 Mouse scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX305 Anti-Cytokeratin 19 (ABT-CK19) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human ABT-CK19 Mouse scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
CAART-LX306 Anti-Cytokeratin 19 (LE64) h(4-1BB-CD3ζ) CAART, pCDCAAR1 Human LE64 Mouse scFv-4-1BB-CD3ζ Lentiviral vector B cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.